E Wangeci Kagucia, Shirine Voller, Abdhalah K Ziraba, Godfrey Bigogo, Patrick K Munywoki, Kimani Makobu, D James Nokes, James Nyagwange, Cameline Orlendo, Donald Akech, Antipa Sigilai, Clayton Onyango, Bonventure Juma, Amy Herman-Roloff, Peninah Munyua, Caroline Apondi, Shirley Lidechi, Allan Audi, Alice Ouma, George Aol, Thomas Misore, Caroline Nasimiyu, Dickens Onyango, Terrence Lo, Kadondi Kasera, Rose Jalang'o, Leonard Kingwara, Ifedayo Adetifa, Anthony O Etyang, George Warimwe, Ambrose Agweyu, J Anthony G Scott
{"title":"简介：肯尼亚多站点服务监测（KEMIS）合作。","authors":"E Wangeci Kagucia, Shirine Voller, Abdhalah K Ziraba, Godfrey Bigogo, Patrick K Munywoki, Kimani Makobu, D James Nokes, James Nyagwange, Cameline Orlendo, Donald Akech, Antipa Sigilai, Clayton Onyango, Bonventure Juma, Amy Herman-Roloff, Peninah Munyua, Caroline Apondi, Shirley Lidechi, Allan Audi, Alice Ouma, George Aol, Thomas Misore, Caroline Nasimiyu, Dickens Onyango, Terrence Lo, Kadondi Kasera, Rose Jalang'o, Leonard Kingwara, Ifedayo Adetifa, Anthony O Etyang, George Warimwe, Ambrose Agweyu, J Anthony G Scott","doi":"10.12688/gatesopenres.15569.2","DOIUrl":null,"url":null,"abstract":"<p><p>The Kenya Multi Site Serosurveillance (KEMIS) collaboration set out to implement an integrated, nationally representative, population-based program of serological surveillance for past infection for a number of important infectious diseases in Kenya. The project started in December 2021 and built on a portfolio of SARS-CoV-2 research conducted in 2020 and 2021. In this profile paper, we describe the background of the KEMIS collaboration, its aim and objectives, the Health and Demographic Surveillance System sites that were involved in data collection, and the key activities undertaken. We also explain how we established governance and management of the KEMIS collaboration, and reflect on opportunities, challenges, lessons learned, and future directions.</p>","PeriodicalId":12593,"journal":{"name":"Gates Open Research","volume":"8 ","pages":"60"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12149407/pdf/","citationCount":"0","resultStr":"{\"title\":\"Profile: The Kenya Multi-Site Serosurveillance (KEMIS) collaboration.\",\"authors\":\"E Wangeci Kagucia, Shirine Voller, Abdhalah K Ziraba, Godfrey Bigogo, Patrick K Munywoki, Kimani Makobu, D James Nokes, James Nyagwange, Cameline Orlendo, Donald Akech, Antipa Sigilai, Clayton Onyango, Bonventure Juma, Amy Herman-Roloff, Peninah Munyua, Caroline Apondi, Shirley Lidechi, Allan Audi, Alice Ouma, George Aol, Thomas Misore, Caroline Nasimiyu, Dickens Onyango, Terrence Lo, Kadondi Kasera, Rose Jalang'o, Leonard Kingwara, Ifedayo Adetifa, Anthony O Etyang, George Warimwe, Ambrose Agweyu, J Anthony G Scott\",\"doi\":\"10.12688/gatesopenres.15569.2\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The Kenya Multi Site Serosurveillance (KEMIS) collaboration set out to implement an integrated, nationally representative, population-based program of serological surveillance for past infection for a number of important infectious diseases in Kenya. The project started in December 2021 and built on a portfolio of SARS-CoV-2 research conducted in 2020 and 2021. In this profile paper, we describe the background of the KEMIS collaboration, its aim and objectives, the Health and Demographic Surveillance System sites that were involved in data collection, and the key activities undertaken. We also explain how we established governance and management of the KEMIS collaboration, and reflect on opportunities, challenges, lessons learned, and future directions.</p>\",\"PeriodicalId\":12593,\"journal\":{\"name\":\"Gates Open Research\",\"volume\":\"8 \",\"pages\":\"60\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-02-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12149407/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gates Open Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12688/gatesopenres.15569.2\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gates Open Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12688/gatesopenres.15569.2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
Profile: The Kenya Multi-Site Serosurveillance (KEMIS) collaboration.
The Kenya Multi Site Serosurveillance (KEMIS) collaboration set out to implement an integrated, nationally representative, population-based program of serological surveillance for past infection for a number of important infectious diseases in Kenya. The project started in December 2021 and built on a portfolio of SARS-CoV-2 research conducted in 2020 and 2021. In this profile paper, we describe the background of the KEMIS collaboration, its aim and objectives, the Health and Demographic Surveillance System sites that were involved in data collection, and the key activities undertaken. We also explain how we established governance and management of the KEMIS collaboration, and reflect on opportunities, challenges, lessons learned, and future directions.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
